- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Incorrect and Missing Author Initials in Affiliations and Authorship Information
Correction to the Trends From the Field article, “Risk Stratification for Return Emergency Department Visits Among High-Risk Patients,” published in the August 2017 issue of The American Journal of Managed Care®.
Am J Manag Care. 2019;25(3):140In the Trends From the Field article, “Risk Stratification for Return Emergency Department Visits Among High-Risk Patients,” published in the August 2017 issue of The American Journal of Managed Care®, an author’s initials were incorrect in the Author Affiliations and Authorship Information sections. The initials for Wei Duan-Porter, MD, PhD, should have been “WD-P.”
Additionally, the initials of another author were inadvertently omitted from the Author Affiliations section. The affiliation of Chad Kessler, MD, should have read “Ambulatory Care Service, Durham VA Medical Center (CK), Durham, NC.”
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
February 20th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes reflections from a thought leader on what has changed over the past 3 decades and what’s next for managed care. The February issue features a retrospective by Richard J. Gilfillan, MD, former director of the Center for Medicare and Medicaid Innovation; and Donald M. Berwick, MD, MPP, former administrator of CMS.
Read More
Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans
February 10th 2025This analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory benefit managers.
Read More
